Scynexis (SCYX) Revenue Growth (1y) (2014 - 2025)
Scynexis (SCYX) Revenue Growth (1y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.91 Bn | 88.04 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.17 Bn | 1.97 Bn | 2.34% |
| 3 | Zoetis | 32.54 Bn | 30.60 Bn | 1.62 Bn | 2.91% |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | -11.85% |
| 5 | United Therapeutics | 23.05 Bn | 20.89 Bn | 648.10 Mn | -1.62% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 7.85% |
| 8 | Neurocrine Biosciences | 17.82 Bn | 16.50 Bn | 800.70 Mn | 42.25% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 14.92% |
| 10 | Scynexis | 23.19 Mn | -13.57 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1,808.50% |
| Sep 30, 2025 | -49.39% |
| Jun 30, 2025 | 85.33% |
| Mar 31, 2025 | -81.28% |
| Dec 31, 2024 | -83.15% |
| Sep 30, 2024 | -62.52% |
| Jun 30, 2024 | -99.44% |
| Mar 31, 2024 | 21.50% |
| Dec 31, 2023 | 280.38% |
| Sep 30, 2023 | 13.10% |
| Jun 30, 2023 | 9,836.05% |
| Mar 31, 2023 | 61.43% |
| Dec 31, 2022 | 155.28% |
| Sep 30, 2022 | 201.74% |
| Mar 31, 2022 | -94.19% |
| Jun 30, 2019 | -10.94% |
| Mar 31, 2019 | 0.00% |
| Dec 31, 2018 | 0.00% |
| Sep 30, 2018 | 0.00% |
| Jun 30, 2018 | 0.00% |